Fecal Lipocalin 2, a Sensitive and Broadly Dynamic Non-Invasive Biomarker for Intestinal Inflammation

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Chassaing, Benoit ^a   Srinivasan, Gayathri ^a   Delgado, Maria A ^b,c   Young, Andrew N ^b,c   Gewirtz, Andrew T ^a,b   Vijay Kumar, Matam ^a  

^a GEORGIA STATE UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Grady Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL1 CHEMOKINE; DEXTRAN SULFATE; INTERLEUKIN 10; INTERLEUKIN 1BETA; MYELOPEROXIDASE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; COLITIS; COLON MUCOSA; CONCENTRATION RESPONSE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES ANALYSIS; FECES LEVEL; FEMALE; HISTOPATHOLOGY; IMMUNOCOMPETENT CELL; MALE; MOUSE; NON INVASIVE MEASUREMENT; NONHUMAN; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS;

ACUTE-PHASE PROTEINS; ANIMALS; BIOLOGICAL MARKERS; CHEMOKINE CXCL1; ENZYME-LINKED IMMUNOSORBENT ASSAY; FECES; FEMALE; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-1BETA; INTESTINES; LIPOCALINS; MALE; MICE; MICE, INBRED C57BL; NEOPLASMS; ONCOGENE PROTEINS; PEROXIDASE; TUMOR NECROSIS FACTOR-ALPHA;

MUS;

EID: 84866015194     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044328     Document Type: Article

References (32)

1. Xavier RJ, Podolsky DK, (2007) Unravelling the pathogenesis of inflammatory bowel disease. Nature 448: 427-434.
2. Cho JH, Brant SR (2011) Recent insights into the genetics of inflammatory bowel disease. Gastroenterology 140: 1704-1712 e1702.
3. Chassaing B, Darfeuille-Michaud A (2011) The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases. Gastroenterology 140: 1720-1728 e1723.
4. Zisman TL, Rubin DT, (2008) Colorectal cancer and dysplasia in inflammatory bowel disease. World journal of gastroenterology: WJG 14: 2662-2669.
5. Lewis JD (2011) The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease. Gastroenterology 140: 1817-1826 e1812.
6. Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, et al. (2011) Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472: 57-63.
7. Vijay-Kumar M, Aitken JD, Carvalho FA, Cullender TC, Mwangi S, et al. (2010) Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 328: 228-231.
8. Kjeldsen L, Cowland JB, Borregaard N, (2000) Human neutrophil gelatinase-associated lipocalin and homologous proteins in rat and mouse. Biochimica et biophysica acta 1482: 272-283.
9. Vijay-Kumar M, Wu H, Jones R, Grant G, Babbin B, et al. (2006) Flagellin suppresses epithelial apoptosis and limits disease during enteric infection. The American journal of pathology 169: 1686-1700.
10. Vijay-Kumar M, Wu H, Aitken J, Kolachala VL, Neish AS, et al. (2007) Activation of toll-like receptor 3 protects against DSS-induced acute colitis. Inflammatory bowel diseases 13: 856-864.
11. Vijay-Kumar M, Sanders CJ, Taylor RT, Kumar A, Aitken JD, et al. (2007) Deletion of TLR5 results in spontaneous colitis in mice. The Journal of clinical investigation 117: 3909-3921.
12. Playford RJ, Belo A, Poulsom R, Fitzgerald AJ, Harris K, et al. (2006) Effects of mouse and human lipocalin homologues 24p3/lcn2 and neutrophil gelatinase-associated lipocalin on gastrointestinal mucosal integrity and repair. Gastroenterology 131: 809-817.
13. Nielsen OH, Gionchetti P, Ainsworth M, Vainer B, Campieri M, et al. (1999) Rectal dialysate and fecal concentrations of neutrophil gelatinase-associated lipocalin, interleukin-8, and tumor necrosis factor-alpha in ulcerative colitis. The American journal of gastroenterology 94: 2923-2928.
14. Parikh CR, Dahl NK, Chapman AB, Bost JE, Edelstein CL, et al. (2012) Evaluation of urine biomarkers of kidney injury in polycystic kidney disease. Kidney Int 81: 784-790.
15. Paragas N, Qiu A, Zhang Q, Samstein B, Deng SX, et al. (2011) The Ngal reporter mouse detects the response of the kidney to injury in real time. Nature medicine 17: 216-222.
16. Meheus LA, Fransen LM, Raymackers JG, Blockx HA, Van Beeumen JJ, et al. (1993) Identification by microsequencing of lipopolysaccharide-induced proteins secreted by mouse macrophages. Journal of immunology 151: 1535-1547.
17. Shen F, Hu Z, Goswami J, Gaffen SL, (2006) Identification of common transcriptional regulatory elements in interleukin-17 target genes. The Journal of biological chemistry 281: 24138-24148.
18. Cowland JB, Muta T, Borregaard N, (2006) IL-1beta-specific up-regulation of neutrophil gelatinase-associated lipocalin is controlled by IkappaB-zeta. Journal of immunology 176: 5559-5566.
19. van Dam RM, Hu FB, (2007) Lipocalins and insulin resistance: etiological role of retinol-binding protein 4 and lipocalin-2? Clinical chemistry 53: 5-7.
20. Wang Y, Lam KS, Kraegen EW, Sweeney G, Zhang J, et al. (2007) Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans. Clinical chemistry 53: 34-41.
21. Yan QW, Yang Q, Mody N, Graham TE, Hsu CH, et al. (2007) The adipokine lipocalin 2 is regulated by obesity and promotes insulin resistance. Diabetes 56: 2533-2540.
22. Zhang J, Wu Y, Zhang Y, Leroith D, Bernlohr DA, et al. (2008) The role of lipocalin 2 in the regulation of inflammation in adipocytes and macrophages. Mol Endocrinol 22: 1416-1426.
23. Catalan V, Gomez-Ambrosi J, Rodriguez A, Ramirez B, Silva C, et al. (2009) Increased adipose tissue expression of lipocalin-2 in obesity is related to inflammation and matrix metalloproteinase-2 and metalloproteinase-9 activities in humans. J Mol Med (Berl) 87: 803-813.
24. Castaneda FE, Walia B, Vijay-Kumar M, Patel NR, Roser S, et al. (2005) Targeted deletion of metalloproteinase 9 attenuates experimental colitis in mice: central role of epithelial-derived MMP. Gastroenterology 129: 1991-2008.
25. Katakura K, Lee J, Rachmilewitz D, Li G, Eckmann L, et al. (2005) Toll-like receptor 9-induced type I IFN protects mice from experimental colitis. The Journal of clinical investigation 115: 695-702.
26. Raffatellu M, George MD, Akiyama Y, Hornsby MJ, Nuccio SP, et al. (2009) Lipocalin-2 resistance confers an advantage to Salmonella enterica serotype Typhimurium for growth and survival in the inflamed intestine. Cell host & microbe 5: 476-486.
27. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W, (1993) Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75: 263-274.
28. Srinivasan G, Aitken JD, Zhang B, Carvalho FA, Chassaing B, et al. (2012) Lipocalin 2 Deficiency Dysregulates Iron Homeostasis and Exacerbates Endotoxin-Induced Sepsis. Journal of immunology. In press, DOI: 10.4049/jimmunol.1200892.
29. Carvalho FA, Koren O, Goodrich JK, Johansson MEV, Nalbantoglu I, et al. (2012) Transient inability to manage proteobacteria promotes chronic gut inflammation in TLR5-deficient mice. Cell host & microbe. In press, DOI: 10.1016/j.chom.2012.07.004.
30. Aadland E, Fagerhol MK, (2002) Faecal calprotectin: a marker of inflammation throughout the intestinal tract. European journal of gastroenterology & hepatology 14: 823-825.
31. Vitali R, Stronati L, Negroni A, Di Nardo G, Pierdomenico M, et al. (2011) Fecal HMGB1 is a novel marker of intestinal mucosal inflammation in pediatric inflammatory bowel disease. The American journal of gastroenterology 106: 2029-2040.
32. Logsdon LK, Mecsas J, (2006) A non-invasive quantitative assay to measure murine intestinal inflammation using the neutrophil marker lactoferrin. J Immunol Methods 313: 183-190.